How ECT’s Exclusive PFAS Remediation Tech Could Transform Soil Cleanup
Environmental Clean Technologies Limited has completed the acquisition of Terrajoule, gaining exclusive rights to a cutting-edge soil remediation technology targeting PFAS contamination. The company also bolstered its leadership and funding to accelerate commercialisation.
- Acquisition of Terrajoule and exclusive license for flash joule heating technology
- Formation of Advisory Board with leading experts in environmental law, chemistry, and industry
- Appointment of Chief Technology Officer to advance proprietary Rapid Electrothermal Mineralisation (REM) technology
- Successful $3 million capital raising supported by strong investor demand
- Ongoing development of COLDry fertiliser technology and potential sale of surplus property
Strategic Acquisition and Technology Licensing
Environmental Clean Technologies Limited (ASX, ECT) has marked a pivotal step in its growth trajectory with the completion of its acquisition of Terrajoule Pty Ltd. This transaction secures an exclusive licence from Rice University to utilise flash joule heating technology, a proprietary method designed to remediate soil contaminated by persistent and hazardous substances such as PFAS (per- and polyfluoroalkyl substances) and heavy metals. This technology, branded as Rapid Electrothermal Mineralisation (REM), positions ECT at the forefront of environmental remediation innovation.
Building Expertise and Leadership
To complement its technological advancements, ECT has established an Advisory Board comprising distinguished figures including environmental law expert Robert Bilott, nanotechnology pioneer Professor James Tour, chemical industry veteran Lewis Utting, and Japanese industrial leader Hirokazu Minami. This diverse panel is tasked with guiding both technical development and commercial strategy, particularly in engaging government stakeholders and industry partners. Additionally, the appointment of Justin Sharp as Chief Technology Officer brings specialised expertise in flash joule heating and mineralisation technologies, further strengthening the company’s capacity to advance REM towards commercial deployment.
Capital Raising and Financial Position
ECT successfully raised $3 million through a two-tranche placement, reflecting robust investor confidence in the company’s strategic direction. The capital injection, supplemented by a convertible note conversion and a government R&D tax incentive rebate, has bolstered the company’s cash reserves to over $3 million. These funds are earmarked to support ongoing research and development, commercial validation, and expansion of remediation opportunities across key jurisdictions.
Ongoing Innovation and Asset Management
Beyond remediation technology, ECT continues to develop its patented COLDry technology via the Zero Quest joint venture, aiming to produce a cost-effective, low-emission fertiliser alternative. Trials underway in South Australia and Victoria are expected to yield results in early 2026. Meanwhile, the company is exploring the sale of its surplus Yallourn property, originally intended for hydrogen refinery development, to streamline its asset portfolio and focus resources on core technologies.
Transitioning to Commercial Execution
The December quarter has been foundational for ECT, transitioning from technology acquisition to active commercialisation. Early technical validation and initial partner discussions are underway, supported by the Advisory Board’s expertise and the CTO’s leadership. The company’s strategy to engage with government agencies and industry stakeholders signals a clear intent to capitalise on growing demand for effective PFAS remediation solutions, a pressing environmental challenge globally.
Bottom Line?
With exclusive technology rights and strengthened leadership, ECT is poised to turn innovation into tangible environmental solutions and shareholder value.
Questions in the middle?
- How soon can ECT expect commercial revenues from the REM technology?
- What are the key regulatory hurdles for PFAS remediation technology adoption in target markets?
- How will the outcomes of COLDry fertiliser trials influence ECT’s diversification strategy?
